HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 210 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.39 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $13,109,781 | -0.6% | 343,188 | -0.9% | 0.08% | 0.0% |
Q2 2023 | $13,187,158 | -0.1% | 346,456 | +0.2% | 0.08% | 0.0% |
Q1 2023 | $13,205,987 | -32.2% | 345,797 | +1.1% | 0.08% | -34.2% |
Q4 2022 | $19,471,179 | +28.1% | 342,200 | -11.0% | 0.11% | +18.8% |
Q3 2022 | $15,205,000 | -19.9% | 384,599 | -10.8% | 0.10% | -13.5% |
Q2 2022 | $18,971,000 | -0.6% | 431,185 | -9.9% | 0.11% | +18.1% |
Q1 2022 | $19,079,000 | +317883.3% | 478,428 | +198417.8% | 0.09% | – |
Q3 2020 | $6,000 | +100.0% | 241 | +61.7% | 0.00% | – |
Q2 2020 | $3,000 | 0.0% | 149 | -25.5% | 0.00% | – |
Q3 2019 | $3,000 | 0.0% | 200 | 0.0% | 0.00% | – |
Q2 2019 | $3,000 | 0.0% | 200 | 0.0% | 0.00% | – |
Q1 2019 | $3,000 | +50.0% | 200 | 0.0% | 0.00% | – |
Q4 2018 | $2,000 | -83.3% | 200 | -68.5% | 0.00% | – |
Q1 2018 | $12,000 | 0.0% | 635 | 0.0% | 0.00% | – |
Q4 2017 | $12,000 | +1100.0% | 635 | +267.1% | 0.00% | – |
Q2 2016 | $1,000 | 0.0% | 173 | 0.0% | 0.00% | – |
Q1 2016 | $1,000 | -80.0% | 173 | -68.1% | 0.00% | – |
Q2 2014 | $5,000 | -44.4% | 543 | -26.9% | 0.00% | – |
Q1 2014 | $9,000 | +12.5% | 743 | +36.8% | 0.00% | – |
Q4 2013 | $8,000 | – | 543 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Security, LLC | 7,048,282 | $126,799,000 | 27.23% |
First Light Asset Management, LLC | 1,630,591 | $29,334,000 | 5.01% |
SNYDER CAPITAL MANAGEMENT L P | 3,393,057 | $61,041,000 | 3.48% |
Bellevue Group AG | 7,663,956 | $137,874,000 | 2.67% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 307,633 | $5,531,000 | 2.52% |
Lombard Odier Asset Management (Switzerland) SA | 900,000 | $16,191,000 | 2.17% |
Elk Creek Partners, LLC | 654,362 | $11,772,000 | 2.02% |
DOHENY ASSET MANAGEMENT /CA | 127,110 | $2,254,000 | 1.79% |
Granite Investment Partners, LLC | 1,277,438 | $22,981,000 | 1.49% |
Amia Capital LLP | 69,409 | $1,249,000 | 1.11% |